Johnson A - Search Results

1

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.

Guigay J, Aupérin A, Fayette J, Saada-Bouzid E, Lafond C, Taberna M, Geoffrois L, Martin L, Capitain O, Cupissol D, Castanie H, Vansteene D, Schafhausen P, Johnson A, Even C, Sire C, Duplomb S, Evrard C, Delord JP, Laguerre B, Zanetta S, Chevassus-Clément C, Fraslin A, Louat F, Sinigaglia L, Keilholz U, Bourhis J, Mesia R; GORTEC; AIO; TTCC, and UniCancer Head and Neck groups. Guigay J, et al. Among authors: johnson a. Lancet Oncol. 2021 Apr;22(4):463-475. doi: 10.1016/S1470-2045(20)30755-5. Epub 2021 Mar 5. Lancet Oncol. 2021. PMID: 33684370 Clinical Trial.

2

Identification of I1171N resistance mutation in ALK-positive non-small-cell lung cancer tumor sample and circulating tumor DNA.

Johnson AC, Dô P, Richard N, Dubos C, Michels JJ, Bonneau J, Gervais R. Johnson AC, et al. Lung Cancer. 2016 Sep;99:38-40. doi: 10.1016/j.lungcan.2016.06.010. Epub 2016 Jun 14. Lung Cancer. 2016. PMID: 27565911

3

Haemoglobin level increase as an efficacy biomarker during axitinib treatment for metastatic renal cell carcinoma: a retrospective study.

Johnson AC, Matias M, Boyle H, Escudier B, Molinier A, Laguerre B, Helissey C, Brachet PE, Dugué AE, Mourey L, Coquan E, Joly F. Johnson AC, et al. BMC Cancer. 2017 May 22;17(1):355. doi: 10.1186/s12885-017-3312-7. BMC Cancer. 2017. PMID: 28532444 Free PMC article.

4

Platinum rechallenge in recurrent head and neck squamous cell carcinoma after primary chemoradiation.

Rambeau A, Licaj I, Gery B, Gervais R, Florescu C, Babin E, De Raucourt D, Johnson A, Thariat J. Rambeau A, et al. Among authors: johnson a. Eur Ann Otorhinolaryngol Head Neck Dis. 2019 Sep;136(4):257-261. doi: 10.1016/j.anorl.2019.04.007. Epub 2019 Apr 16. Eur Ann Otorhinolaryngol Head Neck Dis. 2019. PMID: 31003864 Free article.

5

[Systemic treatments of metastatic or locally recurrent adenoid cystic carcinoma of the head and neck, a systematic review].

Cherifi F, Rambeau A, Johnson A, Florescu C, Géry B, Babin E, Thariat J. Cherifi F, et al. Among authors: johnson a. Bull Cancer. 2019 Oct;106(10):923-938. doi: 10.1016/j.bulcan.2019.05.003. Epub 2019 Jul 16. Bull Cancer. 2019. PMID: 31324333 French.

6

Radiation therapy on primary tumour of synchronous metastatic head and neck squamous cell carcinomas.

Tang É, Nguyen TV, Clatot F, Rambeau A, Johnson A, Sun XS, Tao Y, Thariat J. Tang É, et al. Among authors: johnson a. Cancer Radiother. 2020 Oct;24(6-7):559-566. doi: 10.1016/j.canrad.2020.05.004. Epub 2020 Aug 1. Cancer Radiother. 2020. PMID: 32753240 Review.

7

Flap delineation guidelines in postoperative head and neck radiation therapy for head and neck cancers.

Le Guevelou J, Bastit V, Marcy PY, Lasne-Cardon A, Guzene L, Gerard M, Larnaudie A, Coutte A, Beddok A, Calugaru V, Johnson A, Gery B, Liem X, Pointreau Y, Bourhis J, Thariat J; GORTEC. Le Guevelou J, et al. Among authors: johnson a. Radiother Oncol. 2020 Oct;151:256-265. doi: 10.1016/j.radonc.2020.08.025. Epub 2020 Sep 3. Radiother Oncol. 2020. PMID: 32890610

8

Recurrent anaphylaxis to a gelatin-based colloid plasma substitute and to cetuximab following sensitisation to galactose-alpha-1,3-galactose.

Serrier J, Khoy K, Ollivier Y, Gervais R, Le Moel G, Lafosse M, Johnson A, Le Mauff B, Mariotte D. Serrier J, et al. Among authors: johnson a. Br J Anaesth. 2021 Jun;126(6):e200-e202. doi: 10.1016/j.bja.2021.02.013. Epub 2021 Mar 31. Br J Anaesth. 2021. PMID: 33810867 Free article. No abstract available.

9

A priori quality assurance using a benchmark case of the randomized phase 2 GORTEC 2014-14 in oligometastatic head and neck cancer patients.

Khalladi N, Dejean C, Bosset M, Pointreau Y, Kinj R, Racadot S, Castelli J, Huguet F, Renard S, Guihard S, Tao Y, Rouvier JM, Johnson A, Bourhis J, Xu Shan S, Thariat J. Khalladi N, et al. Among authors: johnson a. Cancer Radiother. 2021 Dec;25(8):755-762. doi: 10.1016/j.canrad.2021.04.005. Epub 2021 Sep 23. Cancer Radiother. 2021. PMID: 34565664 Clinical Trial.

10

Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinoma.

Guiard E, Clatot F, Even C, Perréard M, Abdeddaim C, Johnson A, Vauléon E, Rambeau A. Guiard E, et al. Among authors: johnson a. Eur J Cancer. 2021 Dec;159:125-132. doi: 10.1016/j.ejca.2021.09.025. Epub 2021 Nov 4. Eur J Cancer. 2021. PMID: 34743067

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12,843 results

Search Page